SCHEMBL24264151

SCHEMBL24264151

c1ccc(-c2nc(-c3ccc4c(c3)oc3ccc(-c5cccc6sc7ccccc7c56)cc34)nc(-c3cccc4c3oc3ccccc34)n2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 2/20 0.40
PRKDC P78527 2/20 0.38
BRDT Q58F21 1/20 0.34
PTPRF P10586 5/20 0.34
PTPN2 P17706 5/20 0.34
PTPN1 P18031 5/20 0.34
LIMK1 P53667 1/20 0.34
GGPS1 O95749 1/20 0.34
MAPT P10636 2/20 0.33
ALDH1A1 P00352 2/20 0.33
PIM1 P11309 1/20 0.33
CSNK2A2 P19784 1/20 0.33
CSNK2B P67870 1/20 0.33
PIM3 Q86V86 1/20 0.33
PIM2 Q9P1W9 1/20 0.33
HPGD P15428 1/20 0.33
KDM4E B2RXH2 1/20 0.33
POLB P06746 1/20 0.33
NPSR1 Q6W5P4 1/20 0.32
PTGES2 Q9H7Z7 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23349423 0.96 ALOX5 (0.38) ALOX5PRKDCBRDTPTPRFPTPN2
SCHEMBL23349521 0.96 ALOX5 (0.38) ALOX5PRKDCBRDTPTPRFPTPN2
SCHEMBL23349455 0.96 ALOX5 (0.42) ALOX5PRKDCBRDTPTPRFPTPN2
SCHEMBL23349779 0.96 ALOX5 (0.42) ALOX5PRKDCBRDTPTPRFPTPN2
SCHEMBL23349590 0.94 ALOX5 (0.40) ALOX5PRKDCBRDTLIMK1GGPS1
SCHEMBL23913837 0.94 ALOX5 (0.43) ALOX5PRKDCBRDTGGPS1MAPT
SCHEMBL24216749 0.94 ALOX5 (0.39) ALOX5PRKDCBRDTLIMK1GGPS1
SCHEMBL24215858 0.94 ALOX5 (0.39) ALOX5BRDTPTPRFPTPN2PTPN1
SCHEMBL24264153 0.94 PRKDC (0.35) ALOX5PRKDCBRDTLIMK1MAPT
SCHEMBL24264149 0.94 PRKDC (0.35) ALOX5PRKDCBRDTLIMK1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11832517-B2 Heterocyclic compound and organic light emitting device comprising same LG CHEM, LTD. (KR) 2023-11-28 US disclosed
US-11832517-B2 Heterocyclic compound and organic light emitting device comprising same LG CHEM, LTD. (KR) 2023-11-28 US disclosed
US-20220059778-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2022-02-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220059778-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME CRY1, TRPC1, CYP1A1 ALOX5 1152/4885PRKDC 4335/4885BRDT 2574/4885
US-11832517-B2 Heterocyclic compound and organic light emitting device comprising same CRY1, TRPC1, CYP1A1 ALOX5 1152/4885PRKDC 4335/4885BRDT 2574/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.